Annual short term debt:
$1.78B+$109.00M(+6.52%)Summary
- As of today (September 18, 2025), TEVA annual short term debt is $1.78 billion, with the most recent change of +$109.00 million (+6.52%) on December 31, 2024.
- During the last 3 years, TEVA annual short term debt has risen by +$355.00 million (+24.89%).
- TEVA annual short term debt is now -58.39% below its all-time high of $4.28 billion, reached on December 31, 2011.
Performance
TEVA Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$464.01M+$43.01M(+10.22%)Summary
- As of today (September 18, 2025), TEVA quarterly short term debt is $464.01 million, with the most recent change of +$43.01 million (+10.22%) on June 30, 2025.
- Over the past year, TEVA quarterly short term debt has dropped by -$1.63 billion (-77.84%).
- TEVA quarterly short term debt is now -90.66% below its all-time high of $4.97 billion, reached on September 30, 2008.
Performance
TEVA quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
TEVA Short term debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +6.5% | -77.8% |
3 y3 years | +24.9% | -73.0% |
5 y5 years | -24.1% | -71.9% |
TEVA Short term debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -15.6% | +24.9% | -84.8% | +10.2% |
5 y | 5-year | -44.1% | +24.9% | -86.9% | +10.2% |
alltime | all time | -58.4% | >+9999.0% | -90.7% | +3056.5% |
TEVA Short term debt History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $464.01M(+10.2%) |
Mar 2025 | - | $421.00M(-77.5%) |
Dec 2024 | $1.78B(+6.5%) | $1.87B(-27.6%) |
Sep 2024 | - | $2.58B(+23.2%) |
Jun 2024 | - | $2.09B(-31.6%) |
Mar 2024 | - | $3.06B(+73.0%) |
Dec 2023 | $1.67B(-20.7%) | $1.77B(+19.6%) |
Sep 2023 | - | $1.48B(-25.3%) |
Jun 2023 | - | $1.98B(+93.5%) |
Mar 2023 | - | $1.02B(-53.5%) |
Dec 2022 | $2.11B(+47.9%) | $2.20B(-20.5%) |
Sep 2022 | - | $2.77B(+61.1%) |
Jun 2022 | - | $1.72B(-17.2%) |
Mar 2022 | - | $2.08B(+35.3%) |
Dec 2021 | $1.43B(-55.3%) | $1.53B(-43.3%) |
Sep 2021 | - | $2.71B(-23.3%) |
Jun 2021 | - | $3.53B(+30.9%) |
Mar 2021 | - | $2.70B(-18.4%) |
Dec 2020 | $3.19B(+35.9%) | $3.30B(+56.9%) |
Sep 2020 | - | $2.11B(+27.7%) |
Jun 2020 | - | $1.65B(+1.2%) |
Mar 2020 | - | $1.63B(-33.8%) |
Dec 2019 | $2.35B(+5.8%) | $2.46B(-24.1%) |
Sep 2019 | - | $3.25B(+12.3%) |
Jun 2019 | - | $2.89B(-0.4%) |
Mar 2019 | - | $2.90B(+31.0%) |
Dec 2018 | $2.22B(-39.2%) | $2.22B(-17.1%) |
Sep 2018 | - | $2.67B(+110.1%) |
Jun 2018 | - | $1.27B(-2.3%) |
Mar 2018 | - | $1.30B(-64.3%) |
Dec 2017 | $3.65B(+11.3%) | $3.65B(+33.5%) |
Sep 2017 | - | $2.73B(+119.2%) |
Jun 2017 | - | $1.25B(-35.8%) |
Mar 2017 | - | $1.94B(-40.7%) |
Dec 2016 | $3.28B(+106.7%) | $3.28B(-10.9%) |
Sep 2016 | - | $3.68B(+27.6%) |
Jun 2016 | - | $2.88B(+82.3%) |
Mar 2016 | - | $1.58B(-0.3%) |
Dec 2015 | $1.58B(-10.0%) | $1.58B(-26.2%) |
Sep 2015 | - | $2.15B(-28.9%) |
Jun 2015 | - | $3.02B(+85.9%) |
Mar 2015 | - | $1.63B(-7.7%) |
Dec 2014 | $1.76B(-2.4%) | $1.76B(-3.9%) |
Sep 2014 | - | $1.83B(-10.5%) |
Jun 2014 | - | $2.05B(+32.0%) |
Mar 2014 | - | $1.55B(-14.0%) |
Dec 2013 | $1.80B(-40.0%) | $1.80B(-28.9%) |
Sep 2013 | - | $2.54B(+0.1%) |
Jun 2013 | - | $2.53B(-6.8%) |
Mar 2013 | - | $2.72B(-9.5%) |
Dec 2012 | $3.01B(-29.8%) | $3.01B(+172.8%) |
Sep 2012 | - | $1.10B(-22.4%) |
Jun 2012 | - | $1.42B(-67.5%) |
Mar 2012 | - | $4.37B(+2.0%) |
Dec 2011 | $4.28B | $4.28B(+12.2%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2011 | - | $3.81B(+55.2%) |
Jun 2011 | - | $2.46B(+31.0%) |
Mar 2011 | - | $1.88B(-32.3%) |
Dec 2010 | $2.77B(+113.0%) | $2.77B(+15.1%) |
Sep 2010 | - | $2.41B(+23.7%) |
Jun 2010 | - | $1.95B(-1.4%) |
Mar 2010 | - | $1.97B(+51.5%) |
Dec 2009 | $1.30B(-55.2%) | $1.30B(-11.5%) |
Sep 2009 | - | $1.47B(-27.7%) |
Jun 2009 | - | $2.04B(-39.1%) |
Mar 2009 | - | $3.35B(+14.1%) |
Dec 2008 | $2.91B(+57.8%) | $2.93B(-41.0%) |
Sep 2008 | - | $4.97B(+247.2%) |
Jun 2008 | - | $1.43B(-29.8%) |
Mar 2008 | - | $2.04B(+10.6%) |
Dec 2007 | $1.84B(+148.1%) | $1.84B(-5.7%) |
Sep 2007 | - | $1.95B(+28.1%) |
Jun 2007 | - | $1.52B(+0.2%) |
Mar 2007 | - | $1.52B(+104.7%) |
Dec 2006 | $742.00M(+97.3%) | $742.88M(+0.8%) |
Sep 2006 | - | $736.69M(-30.1%) |
Jun 2006 | - | $1.05B(-0.6%) |
Mar 2006 | - | $1.06B(+182.4%) |
Dec 2005 | $376.00M(-32.9%) | $375.68M(-3.7%) |
Sep 2005 | - | $389.92M(-7.0%) |
Jun 2005 | - | $419.40M(-16.6%) |
Mar 2005 | - | $502.95M(-10.3%) |
Dec 2004 | $560.00M(-13.1%) | $560.40M(+25.9%) |
Sep 2004 | - | $445.21M(+29.0%) |
Jun 2004 | - | $345.16M(-3.2%) |
Mar 2004 | - | $356.45M(-44.7%) |
Dec 2003 | $644.20M(-12.8%) | $644.06M(-44.4%) |
Sep 2003 | - | $1.16B(+57.0%) |
Dec 2002 | $738.50M(+257.6%) | $738.21M(+386.6%) |
Jun 2002 | - | $151.70M(-26.5%) |
Dec 2001 | $206.52M(-39.5%) | $206.52M(-39.5%) |
Dec 2000 | $341.52M(+23.6%) | $341.52M(-33.6%) |
Jun 2000 | - | $514.06M(+77.8%) |
Mar 2000 | - | $289.13M(-13.0%) |
Dec 1999 | $276.26M(-14.9%) | - |
Dec 1998 | $324.50M(+35.3%) | - |
Sep 1998 | - | $332.30M(+24.9%) |
Jun 1998 | - | $266.10M(+21.3%) |
Mar 1998 | - | $219.30M(-8.5%) |
Dec 1997 | $239.80M(-29.7%) | $239.80M(-29.7%) |
Dec 1996 | $341.20M(+33.7%) | $341.20M(+33.7%) |
Dec 1995 | $255.20M(+84.5%) | $255.20M(+84.5%) |
Dec 1994 | $138.30M(+26.5%) | $138.30M(+26.5%) |
Dec 1993 | $109.30M(+13.0%) | $109.30M(+13.0%) |
Dec 1992 | $96.70M(+69.4%) | $96.70M(+69.4%) |
Dec 1991 | $57.10M(+3.1%) | $57.10M(+3.1%) |
Dec 1990 | $55.40M(+122.5%) | $55.40M(+122.5%) |
Dec 1989 | $24.90M(-27.6%) | $24.90M(-27.6%) |
Dec 1988 | $34.40M(+134.0%) | $34.40M(+134.0%) |
Mar 1987 | $14.70M(0.0%) | $14.70M(0.0%) |
Mar 1986 | $14.70M | $14.70M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual short term debt?
- What is the all time high annual short term debt for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual short term debt year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly short term debt?
- What is the all time high quarterly short term debt for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly short term debt year-on-year change?
What is Teva Pharmaceutical Industries Limited annual short term debt?
The current annual short term debt of TEVA is $1.78B
What is the all time high annual short term debt for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual short term debt is $4.28B
What is Teva Pharmaceutical Industries Limited annual short term debt year-on-year change?
Over the past year, TEVA annual short term debt has changed by +$109.00M (+6.52%)
What is Teva Pharmaceutical Industries Limited quarterly short term debt?
The current quarterly short term debt of TEVA is $464.01M
What is the all time high quarterly short term debt for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly short term debt is $4.97B
What is Teva Pharmaceutical Industries Limited quarterly short term debt year-on-year change?
Over the past year, TEVA quarterly short term debt has changed by -$1.63B (-77.84%)